50

Cryptosporidiosis in a young immunocompromised patient

Embed Size (px)

DESCRIPTION

Cryptosporidium is a pathogen of significant public health issue especially in developing countries where water filtration and treatment is not up to the standards.

Citation preview

Page 1: Cryptosporidiosis in a young immunocompromised patient
Page 2: Cryptosporidiosis in a young immunocompromised patient

Consultant Microbiologist AFIP Rawalpindi

Cryptosporidiosis in a young immunocompromised patient

Dr Shams AfridiTrainee in Microbiology

SupervisorDr Nasrullah Malik

Page 3: Cryptosporidiosis in a young immunocompromised patient

Case Presentation

Page 4: Cryptosporidiosis in a young immunocompromised patient

Name XYZ

Age 12 years

Gender Male

Residence Peshawar

Date of admission 28 Aug 2009

Hospital AFBMTC

PATIENT’S PROFILE

Page 5: Cryptosporidiosis in a young immunocompromised patient

● Watery diarrhoea 3 days

● Low grade fever

● Non productive cough 2 days

PRESENTING COMPLAINTS

Page 6: Cryptosporidiosis in a young immunocompromised patient

● Known case of Fanconi’s anemia

● Allogenic bone marrow transplant at AFBMTC Rwp on 10th Aug 2009

● Discharged after two weeks

● Re-admitted on Aug 28, with symptoms of acuteGvHD

● HISTORY OF PRESENT ILLNESS

Page 7: Cryptosporidiosis in a young immunocompromised patient

● Non-bloody, watery diarrhoea with 15-20 stools per day

● Low grade fever

● Developed non productive cough with

breathlessness

● HISTORY OF PRESENT ILLNESS

Page 8: Cryptosporidiosis in a young immunocompromised patient

● Cyclosporine , steroids , immunoglobulins

● Antibiotic therapy including antifungal agents

● Fluid and electrolyte replacement

● Condition remained the same

● HISTORY OF PRESENT ILLNESS

Page 9: Cryptosporidiosis in a young immunocompromised patient

● PAST HISTORY

● Frequent admissions in AFBMTC

● Fanconi's anemia diagnosed in May, 2009

at AFBMTC

● Bone marrow transplantation at AFBMTC

● Was on oral immunosuppressive therapy

Page 10: Cryptosporidiosis in a young immunocompromised patient

● SOCIOECONOMIC HISTORY

Socioeconomic status satisfactory

● PERSONAL HISTORY

Not contributory

● FAMILY HISTORY

Not contributory

Page 11: Cryptosporidiosis in a young immunocompromised patient

A boy of lean built lying in bed conscious and oriented

Vital signs

GENERAL PHYSICAL EXAMINATION

Page 12: Cryptosporidiosis in a young immunocompromised patient

● Pallor +

● Jaundice +

● Dehydration + +

● Cyanosis

● Clubbing

● Edema Absent

● Lymphadenopathy

● Ascites

GENERAL PHYSICAL EXAMINATION

Page 13: Cryptosporidiosis in a young immunocompromised patient

GIT - Hepatosplenomegaly

RESP - NAD

CNS - NAD

CVS - NAD

SYSTEMIC EXAMINATION

Page 14: Cryptosporidiosis in a young immunocompromised patient

● Acute graft versus host disease

● Bacterial, viral and protozoal causes of watery diarrhoea

● Atypical pneumonia

● Bacteraemia/Septicaemia

PROVISIONAL DIAGNOSIS

Page 15: Cryptosporidiosis in a young immunocompromised patient

● Blood C/P

Hb 9.5 g /dl

WBC 2.1 x 109/l

Platelets 51 x 109/l

● Urine R/E WNL

● Fasting plasma Glucose 4.8 mmol/l

LAB EVALUATION

Page 16: Cryptosporidiosis in a young immunocompromised patient

● Renal function tests

Serum urea 2.9mmol/l

Serum creatinine 68 μmol/l

Serum Na 136mmol/l

Serum K 3.8mmol/l

Serum HCO3 23mmol/l

● Liver Function Tests

Bilirubin 70 μ mol/l

ALT 75 U/l

ALP 708 U/l

Albumin 19 g/l (reduced)

LAB EVALUATION (Cont’d)

Page 17: Cryptosporidiosis in a young immunocompromised patient

● CXR

Normal

● USG abdomen

Mild hepatosplenomegaly

● Repeated blood cultures

No growth

LAB EVALUATION (Cont’d)

Page 18: Cryptosporidiosis in a young immunocompromised patient

● Stool routine examination

Loose watery stools

Numerous pus cells

No ova or cysts

● Stool for culture and sensitivity

No Salmonella, Shigella or Vibrio cholerae

● Sputum for C/S and AFB

AFB not seen

Culture Non significant ( normal throat flora )

LAB EVALUATION (Cont’d)

Page 19: Cryptosporidiosis in a young immunocompromised patient

● Stool for Clostridium difficile toxin

Negative

● Stool for Cryptosporidium

Cysts of Cryptosporidium parvum

• Sputum for Cryptosporidium

Cysts of Cryptosporidium parvum

LAB EVALUATION (Cont’d)

Page 20: Cryptosporidiosis in a young immunocompromised patient

Cysts of Cryptosporidium parvum in stool

Page 21: Cryptosporidiosis in a young immunocompromised patient

Cysts of Cryptosporidium parvum in sputum

Page 22: Cryptosporidiosis in a young immunocompromised patient

Intestinal and pulmonary cryptosporidiosis

FINAL DIAGNOSIS

Page 23: Cryptosporidiosis in a young immunocompromised patient

• Supportive therapyo I/V Fluidso Antiemeticso Antipyretics

● Syp Azithromycin (200mg/ 5ml) 1 TSF BD

● Tab Cotrimoxazole 480mg 8 hourly

● Frequency of diarrhea reduced to 5-6 stools per day● Pulmonary symptoms improved

TREATMENT

Page 24: Cryptosporidiosis in a young immunocompromised patient

Repeat stool sample No cyst Repeat sputum sample ● Condition started to deteriorate

CMV PCR ---- Positive

o Put on Gancyclovir and I/V Immunoglobulins Oct 7, Epileptic fit with tongue bite

Bilateral bronchopneumonia

Respiratory failure and death

TREATMENT

Page 25: Cryptosporidiosis in a young immunocompromised patient

Case Discussion

Page 26: Cryptosporidiosis in a young immunocompromised patient

● Cryptosporidium — “hidden spores”

● Phylum Apicomplexa (the sporozoa)o Coccidian protozoan parasite

● Important Specieso C. parvumo C. hominiso C. muriso C. wrairi

● Oocyst 4-6μm in dm

● 240,000 times resistant to chlorination than Giardia

INTRODUCTION

Page 27: Cryptosporidiosis in a young immunocompromised patient

● 1907 Tyzzer, gastric mucosa of mice

● 1976 First human case — 3-year old girl rural

Tennessee, USA

● 1980s Strong association with AIDS

Most common cause of

HIV related gastroenteritis

HISTORICAL BACKGROUND

Page 28: Cryptosporidiosis in a young immunocompromised patient

● Infection reported in six continents

● 3 days to 95 years old

● The frequency of cryptosporidiosis not well-defined o 30% of adult US population seropositive

● A local prospective study conducted at AFIP (May to September 2005)

(n=300) 8%

92%

present absent

EPIDEMIOLOGY

* Hunter PR, Nichols G. Epidemiology and clinical features ofCryptosporidium infection in immunocompromised patients.Clin Microbiol Rev 2002; 15: 145–54.

Page 29: Cryptosporidiosis in a young immunocompromised patient

● Population at risk

o Immunocompromised individuals

o Infants and young children (day-care centres)

o Drinking unfiltered and untreated water

o Hospitalized patients & Health-care employees

o Livestock workers and farmers

o Travelers to endemic areas

EPIDEMIOLOGY (Cont’d)

Page 30: Cryptosporidiosis in a young immunocompromised patient

Year Location Population exposed

Population infected

1984 Braun station, Texas 50900 2006

1992 Jackson county, Oregon 15000 15000

1993 Milwaukee, Wisconsin 403,000 403,000

1996 British Columbia, Canada 90,000 15000

2001 Belfast , Ireland 252,000 257

2007 Galway, Ireland 90,000 5000

2008 Northampton, UK 108,000 252

MAJOR OUTBREAKS

MacKenzie WR, Hoxie NJ, Proctor ME, Gradus MS, Blair KA, Peterson DE, Kazmierczak JJ, Addiss DG, Fox KR, Rose JB. Amassive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply. N Engl J Med 1994; 331: 161–7.

Page 31: Cryptosporidiosis in a young immunocompromised patient

Life cycle of Cryptosporidium

Page 32: Cryptosporidiosis in a young immunocompromised patient

● Fecal-oral

o Contaminated food and water

o Untreated groundwater, well water

o Swimming pools, water park wave pools

TRANSMISSION

Page 33: Cryptosporidiosis in a young immunocompromised patient

● Food borne transmission

o Beverages, salads, or other foods not heated or cooked after handling.

● Day-care and Nursing centres

● Nosocomial transmission

o Patients to health care staff, patient-to-patient transmission

TRANSMISSION (Cont’d)

Guerrant R.L. Cryptosporidiosis: An emerging highly infectious threat. Emerg Infect Dis 1997;3:51-7.  

Page 34: Cryptosporidiosis in a young immunocompromised patient

● Low infectious dose

● Sporozoites adhere to the intestinal mucosa

● Cells release cytokines-activate phagocytes

● Soluble factors are released

● Increase intestinal secretion of water and chloride and inhibit absorption

PATHOGENESIS

Page 35: Cryptosporidiosis in a young immunocompromised patient

● Epithelial cells damaged by:

o Direct parasite invasion and multiplication or

o T cell-mediated-villus atrophy

PATHOGENESIS (Cont’d)

Page 36: Cryptosporidiosis in a young immunocompromised patient

● Incubation periodo 2 – 10 days

● Immunocompetent patients

● Acute self-limitingo Frequent, watery diarrhea o Nausea o Vomiting o Abdominal cramps o Low-grade fever

Henry MC, Alary M, Desmet P, et al. Community survey of diarrhoea in children under 5 years in Kinshasa, Zaire. Ann SocBelg Med Trop 1995;75:105–14. [PubMed: 7487197]

CLINICAL MANIFESTATIONS

Page 37: Cryptosporidiosis in a young immunocompromised patient

● Immunocompromised patients- more severe illness

o Cholera-like diarrhea (up to 20 liters/day) o Severe abdominal cramps o Malaise o Low grade fever o Weight loss o Anorexia

CLINICAL MANIFESTATIONS(Cont’d)

Kumar S.S., Ananthan S., Saravanan P. Role of coccidian parasites in causation of diarrhea in HIV infected patients in Chennai. Indian J Med Res 2002;116:85-9. 

Page 38: Cryptosporidiosis in a young immunocompromised patient

● Pulmonary involvement

● Rare complication of intestinal cryptosporidiosis

o Chronic cougho Fever o Dyspnoea

Moore, J., and J. Frenkel. 2005. Respiratory and enteric cryptosporidiosis in humans. Arch. Pathol. Lab. Med. 115:1160–1162.

CLINICAL MANIFESTATIONS(Cont’d)

Page 39: Cryptosporidiosis in a young immunocompromised patient

● Microscopic examination

● Serological investigations

o Enzyme immunoassays

o Immunofluorescence assays

● Molecular techniques

LABORATORY DIAGNOSIS

Mehta P. Laboratory diagnosis of cryptosporidiosis. J Postgrad Med 2002;48:217

Page 40: Cryptosporidiosis in a young immunocompromised patient

● MICROSCOPIC EXAMINATION

o Most reliable and specifico Gold standard-Modified ZN (Kinyoun) stainingo Cysts: Bright red, round to oval (4-6 µm)

LABORATORY DIAGNOSIS (Cont’d)

Page 41: Cryptosporidiosis in a young immunocompromised patient

● MICROSCOPIC EXAMINATION

o Auramine-phenol (fluorescent stain)o Cysts appear small, round and bright yellowo False positive results

LABORATORY DIAGNOSIS (Cont’d)

Page 42: Cryptosporidiosis in a young immunocompromised patient

● SEROLOGICAL METHODS

● ELISA o Cryptosporidium specific IgM, IgG, IgAo Sensitivity: 80-100 %o Active infection / previous exposure

LABORATORY DIAGNOSIS (Cont’d)

Marques FR, Cardoso LV, et al. Performance of an immunoenzymatic assay for Cryptosporidium diagnosis of fecal samples; Braz J Infect Dis. 2005 Feb;9(1):3-5. Epub 2005 Jun 6.

Page 43: Cryptosporidiosis in a young immunocompromised patient

● SEROLOGICAL METHODS

● IMMUNOFLUORESCENCE ASSAYS o Sensitiveo Specifico High cost

LABORATORY DIAGNOSIS (Cont’d)

Mehta P. Laboratory diagnosis of cryptosporidiosis. J Postgrad Med 2002;48:217

Page 44: Cryptosporidiosis in a young immunocompromised patient

● Rapid Immunochromatographic detection

o 97% sensitivityo 100% specificity

o High cost

LABORATORY DIAGNOSIS (Cont’d)

LYNNE S. GARCIA* AND ROBYN Y. SHIMIZU. Detection of Giardia lamblia and Cryptosporidium parvumAntigens in Human Fecal Specimens Using the ColorPAC Combination Rapid Solid-Phase Qualitative Immunochromatographic Assay ; JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 2000, p. 1267–1268

Page 45: Cryptosporidiosis in a young immunocompromised patient

● MOLECULAR METHODS

● Polymerase chain reaction(PCR)

o Speciation of cryptosporidiumo Epidemiological studieso Expensiveo Not used as routine

● INTESTINAL BIOPSY SECTIONSo False negative results

LABORATORY DIAGNOSIS (Cont’d)

Page 46: Cryptosporidiosis in a young immunocompromised patient

● No reliable effective therapy

● In immunocompetent patients

o Self limiting

o General supportive care

o Rehydration, replacement of electrolytes and antimotility agents

o Nitazoxanide, Paromomycin and Azithromycin

decrease the intensity of infection*

* De la Tribonnière X, Valette M, Alfandari S. Oral nitazoxanide and paromomycin inhalation for systemic cryptosporidiosis in a patient with AIDS. Infection 1999 May-Jun; 27(3): 232.

TREATMENT

Page 47: Cryptosporidiosis in a young immunocompromised patient

● In immunocompromised patients

o Resolves slowly or not at all

● Spiramycin in the early stages

● Paromomycin and Azithromycin help clear the infection*

● Immunoglobulins

* Palmieri F, Cicalini S, Froio N, Rizzi EB, Goletti D, Festa A, et al. Pulmonary cryptosporidiosis in an AIDS patient: successful treatment with paromomycin plus azithromycin. Int J STD AIDS. 2005 Jul; 16(7): 515-7.

TREATMENT(Cont’d)

Page 48: Cryptosporidiosis in a young immunocompromised patient

● Personal hygieneo Hand washing

● Avoid water that might be contaminatedo Do not swallow recreational watero Avoid swimming when having diarrhoeao Boil water for 1 min or use 1 micron filter

● Avoid food that might be contaminated

● Take extra care when travelling

PREVENTION

Havelaar A, Boonyakarnkul T, Cunliffe D, Grabow W, Sobsey M, Giddings M, Magara Y, Ohanian E, Toft P, Chorus I, Cotruvo J, Howard G, Jackson P. Guidelines for Drinking Water Quality Water Borne Pathogens, 3rd edn. Geneva: WHO 2003.

Page 49: Cryptosporidiosis in a young immunocompromised patient

● Stool sample for Cryptosporidium oocysts should always be sent to laboratory in cases of persistent diarrhoea

● Pulmonary cryptosporidiosis is an important but rare cause of pneumonia/mortality in immunocompromised patients

CONCLUSION

Page 50: Cryptosporidiosis in a young immunocompromised patient

THANK YOU !